Lymphoma, Non Hodgkin Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Recruiting
  • Lymphocytic Leukemia, Chronic
  • Lymphoma, Non Hodgkin
  • BTCT4465A (Mosunetuzumab) IV
  • +2 more
  • Duarte, California
  • +55 more
2022-03-17
Mar 17, 2022
G
A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma - 2018
Completed
Has Results
  • Lymphoma, Non Hodgkin
  • Birmingham, Alabama
  • +10 more
2020-02-18
Feb 18, 2020
H
MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma - 2017
Completed
Has Results
  • Lymphoma, Non Hodgkin
  • Vitoria, Alava, Spain
  • +38 more
2018-12-04
Dec 4, 2018
G
An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma - 2014
Completed
  • Lymphoma, Non Hodgkin
    • (no location specified)
    2017-03-21
    Mar 21, 2017